HR 2482 · 116th Congress 2019–2021, ended

Mainstreaming Addiction Treatment Act of 2019

Latest action · May 31, 2019 Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 2, 2019
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Mainstreaming Addiction Treatment Act of 2019

This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment).

Further, the bill directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.

Cosponsors 117

Members who signed on, in the order they did. Signatures ran from May 2, 2019 to Dec 16, 2020; 5 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-NYAntonio DelgadoOriginalMay 2, 2019
D-NMBen Ray LujánOriginalMay 2, 2019
R-NYElise M. StefanikOriginalMay 2, 2019
R-OHMichael R. TurnerOriginalMay 2, 2019
R-NCTed BuddOriginalMay 2, 2019
D-CADoris O. MatsuiMay 7, 2019
D-NYGregory W. MeeksMay 7, 2019
D-CAHarley RoudaMay 7, 2019
D-NJJefferson Van DrewMay 7, 2019
D-TXLloyd DoggettMay 7, 2019
R-NCMark MeadowsMay 7, 2019
D-WAPramila JayapalMay 7, 2019
D-NYYvette D. ClarkeMay 7, 2019
D-NJAlbio SiresMay 9, 2019
D-NYAnthony BrindisiMay 9, 2019

Committees 3

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred May 2, 2019
Health Subcommittee
Referred May 3, 2019
HouseJudiciary Committee
Referred May 2, 2019
Crime and Federal Government Surveillance Subcommittee
Referred May 31, 2019
HouseWays and Means Committee
Referred May 2, 2019

Actions 4

Everything that happened, newest first.

  1. May 31, 2019Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  2. May 3, 2019Referred to the Subcommittee on Health.
  3. May 2, 2019Introduced in House
  4. May 2, 2019Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In the Congressional Record 2

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H7998Antonio Delgado D-NYSep 26, 2019
HouseDebate and remarks H3508Antonio Delgado D-NYMay 9, 2019

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, Clause 3

The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 72, May 2, 2019, page H3441.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 116-106COMBATING AN EPIDEMIC: LEGISLATION TO HELP PATIENTS WITH SUBSTANCE USE DIS- SORDERS356 pagesEnergy and Commerce CommitteeMar 3, 2020

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 2074Mainstreaming Addiction Treatment Act of 2019Related billJul 10, 2019

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V (such as buprenorphine) for maintenance or detoxificattion treatment, and for other purposes.
Short Title(s) as Introduced
Mainstreaming Addiction Treatment Act of 2019

Subjects

Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.

Text 1

Each version as it was printed, newest first.

  1. May 2, 2019Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.